InsidersTradesSigma
神州细胞 Stock: price and insider trades · China · SSE / SZSE (CSRC)
Track the 神州细胞 stock price and the full management transaction log of the company, a listed equity based in China. Shares are quoted on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 神州细胞 has logged 7 public disclosures. Market capitalisation: €19.3bn. The latest transaction was filed on 5 July 2022 (Purchase). Among the most active insiders: 谢良志. The full history is openly available.
7
Insider Decl.
0
Thresholds
·
7 ops.
Buy Volume
·
0 ops.
Sell Volume
22Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 20,984 of 25,804 companies
29.8
score / 100
Value26
Quality34
FCF yld-2.8%
Earn yld-3.2%
EV/EBITDA·
ROE-157%
Gross mgn93%
Net mgn-36%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 5 July 2022
Declarations7 total
180,000 sharesA股XSHGSSE:173000005652000060
Ideal exit: 1 Apr 2023 (T+270)
7 of 7 declarations